Calendar CNS Pharmaceuticals, Inc.

Equities

CNSP

US18978H2013

Market Closed - Nasdaq 02:00:00 27/04/2024 am IST 5-day change 1st Jan Change
0.215 USD +5.39% Intraday chart for CNS Pharmaceuticals, Inc. +6.44% -83.07%

Chart calendar CNS Pharmaceuticals, Inc.

add23d9.xqgofipbvmkBxp8hsejH36lbvFlVJ-0aWbC1wZa6fqg.gP9tLX4o7Dp3kcVU-K-DpdAujzpiSrJoLcH7k8eMNOqqhV47SBD5UUSLyg~e41e80dfde8cf32dc2e27a547613840c

Upcoming events on CNS Pharmaceuticals, Inc.

Today 08:45 pm LSX World Congress
30/04/2024 Annual General Meeting
13/05/2024 Q1 2024 Earnings Release (Projected)
12/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)

Past events on CNS Pharmaceuticals, Inc.

09/04/2024 10:30 pm LD Micro Invitational Conference
05/04/2024 01:55 am MedInvest Biotech & Pharma Investor Conference
15/11/2023 06:30 pm Q3 2023 Earnings Release
15/11/2023 Society of NeuroOncology Meeting
25/10/2023 01:30 am Ask The CEO Virtual Investor Conference
15/09/2023 12:30 am Annual General Meeting
13/09/2023 08:00 pm H.C. Wainwright Global Investment Conference
14/08/2023 05:05 pm Q2 2023 Earnings Release
11/08/2023 06:00 am SNO/ASCO CNS Cancer Conference - Abstract Code: TIPS-20
03/08/2023 09:05 pm Benzinga Virtual Biotech Conference
11/07/2023 09:30 pm Virtual Investor Summer Spotlight Conference
22/06/2023 12:00 am Maxim Group Virtual Healthcare Conference
15/05/2023 06:05 pm Q1 2023 Earnings Release
03/05/2023 09:30 pm Virtual Investor Spotlight Conference
05/04/2023 12:30 am Investor Meeting - Key Opinion Leader
03/04/2023 05:35 pm Q4 2022 Earnings Release
18/01/2023 08:30 pm Virtual Investor Conference
06/12/2022 09:30 pm Ask the CEO Virtual Investor Conference
15/11/2022 02:35 am Q3 2022 Earnings Release
28/09/2022 10:30 pm Oncology Spotlight Featuring CNS Pharmaceuticals Virtual Investor Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-3,83
-1,40
-173.78%
-9,45
-8,51
-11.06%
-14,0
-15,7
10.51%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,88
-1,50
-158.48%
-9,46
-8,51
-11.1%
-14,0
-15,7
10.5%
Net income
Million USD
Released
Forecast
Spread
-3,88
-1,50
-158.48%
-9,46
-8,51
-11.1%
-14,0
-15,7
10.5%
EPS
USD
Released
Forecast
Spread
-8,40
-3,30
-154.55%
-17,1
-15,1
-13.43%
-15,9
-17,9
10.92%
Announcement Date12/03/2012/02/2103/03/22

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2023 Q2 2023 Q3
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-2,79
-4,44
37.11%
-2,78
-4,24
34.39%
-3,56
-3,15
-13.19%
-3,42
-3,85
11.29%
-4,03
-5,38
25.14%
-4,53
-5,89
23.02%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-2,80
-4,44
37.07%
-2,78
-4,24
34.33%
-3,57
-3,15
-13.24%
-3,42
-3,85
11.27%
-4,02
-5,38
25.21%
-4,52
-5,89
23.21%
Net income
Million USD
Released
Forecast
Spread
-2,80
-4,44
37.07%
-2,78
-4,24
34.33%
-3,57
-3,15
-13.24%
-3,42
-3,85
11.27%
-4,02
-5,38
25.21%
-4,52
-5,89
23.21%
EPS
USD
Released
Forecast
Spread
-3,00
-4,80
37.5%
-2,10
-3,30
36.36%
-2,70
-2,40
-12.5%
-2,70
-3,00
10%
-1,04
-2,82
63.12%
-1,08
-1,73
37.57%
Announcement Date03/03/2213/05/2212/08/2210/11/2214/08/2314/11/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CNSP Stock
  4. Calendar CNS Pharmaceuticals, Inc.